BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Takeda Pharmaceutical Co. Ltd. 

1-1, Doshomachi 4-chome

Chuo-ku  Osaka  540-8645  Japan
Phone: 81-6-6204-2111 Fax: 81-6-6204-2880


SEARCH JOBS

View Clinical Trials from BioPharm Insight




 Key Statistics


Email: n/a
Ownership:

Web Site: Takeda Pharmaceutical Co. Ltd.
Employees:
Symbol: TKPYY
 



Industry
Pharmaceutical






 Company News
German Database Study Hints Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Diabetes Drug Cuts Alzheimer's Risk 7/14/2014 7:29:54 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) And Zinfandel Pharmaceuticals Inc. To Present Data At Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches To Alzheimer's Disease Research And Development 7/10/2014 10:43:47 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) COO Dreams Big, Seeks Deals And Global Push In Turnaround Effort 7/3/2014 8:10:29 AM
Ex-Employees, Investors Attack Takeda Pharmaceutical Co. Ltd. (TKPYY) For Hiring Foreign Executives 6/23/2014 6:35:58 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Legal-Bay Lawsuit Settlement Funding Reports $9 Billion In The First Actos (Pioglitazone) Settlement 6/19/2014 6:35:56 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/19/2014 6:09:16 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Results Of A New Study Of Brintellix® (vortioxetine) vs. Escitalopram On Sexual Functioning In Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction 6/17/2014 11:03:37 AM
Affymax, Inc. (AFFY) Drug Omontys® Terminal As Takeda Pharmaceutical Co. Ltd. (TKPYY) Switches Off Support 6/16/2014 10:49:39 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014 8:42:10 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release:New CONNECT Study Presents Data On Measures Of Cognitive Performance In Adult Patients Treated With Brintellix® (Vortioxetine) For Major Depressive Disorder 6/16/2014 7:27:53 AM
12345678910...